Preparation and anti-HIV activity of N-3 amino substituted thymidine nucleoside analogs
- 31 December 1992
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 2 (12) , 1469-1474
- https://doi.org/10.1016/s0960-894x(00)80410-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Synthesis and Anti-human Immunodeficiency Virus Type 1(HIV-1) Activity of 3-Substituted Derivatives of 3'-Azido-3'-deoxythymidine (AZT), and Inhibition of HIV-1 Reverse Transcriptase by Their 5'-Triphosphates.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- Computer-assisted structure-activity correlations of dideoxynucleoside analogs as potential anti-HIV drugsAntiviral Research, 1990
- Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1Antimicrobial Agents and Chemotherapy, 1989
- 1-(2,3-Dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agentJournal of Medicinal Chemistry, 1989
- Comparative activity of 2′,3′-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cellsBiochemical Pharmacology, 1988
- Anti-retrovirus activity of 3′-fluoro- and 3′-azido-substituted pyrimidine 2′,3′-dideoxynucleoside analoguesBiochemical Pharmacology, 1988
- Enhanced In Vitro Inhibition of HIV-1 Replication by 3′-Fluoro-3′-deoxythymidine Compared to Several Other Nucleoside AnalogsAIDS Research and Human Retroviruses, 1988
- 3'-Substituted 2',3'-dideoxynucleoside analogs as potential anti-HIV (HTLV-III/LAV) agentsJournal of Medicinal Chemistry, 1987
- Synthesis and antiviral activity of various 3'-azido, 3'-amino, 2',3'-unsaturated, and 2',3'-dideoxy analogs of pyrimidine deoxyribonucleosides against retrovirusesJournal of Medicinal Chemistry, 1987
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences, 1985